These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37624230)

  • 1. Reevaluating First-line Therapies in Youth-Onset Type 2 Diabetes.
    Chung ST; Davis F; Patel T; Mabundo L; Estrada DE
    J Clin Endocrinol Metab; 2024 Jan; 109(2):e870-e872. PubMed ID: 37624230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes.
    ; Zeitler P; Epstein L; Grey M; Hirst K; Kaufman F; Tamborlane W; Wilfley D
    Pediatr Diabetes; 2007 Apr; 8(2):74-87. PubMed ID: 17448130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approach to the Patient: Youth-Onset Type 2 Diabetes.
    Hitt TA; Hannon TS; Magge SN
    J Clin Endocrinol Metab; 2023 Dec; 109(1):245-255. PubMed ID: 37584397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin in the treatment of obese children and adolescents at risk of type 2 diabetes.
    Kendall DL; Amin R; Clayton PE
    Paediatr Drugs; 2014 Feb; 16(1):13-20. PubMed ID: 23949947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin improves blood glucose by increasing incretins independent of changes in gluconeogenesis in youth with type 2 diabetes.
    Cravalho CKL; Meyers AG; Mabundo LS; Courville A; Yang S; Cai H; Dai Y; Walter M; Walter PJ; Sharma S; Chacko S; Cogen F; Magge SN; Haymond MW; Chung ST
    Diabetologia; 2020 Oct; 63(10):2194-2204. PubMed ID: 32728891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world treatment escalation from metformin monotherapy in youth-onset Type 2 diabetes mellitus: A retrospective cohort study.
    Vajravelu ME; Hitt TA; Amaral S; Levitt Katz LE; Lee JM; Kelly A
    Pediatr Diabetes; 2021 Sep; 22(6):861-871. PubMed ID: 33978986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists : A Cost-Effectiveness Study.
    Choi JG; Winn AN; Skandari MR; Franco MI; Staab EM; Alexander J; Wan W; Zhu M; Huang ES; Philipson L; Laiteerapong N
    Ann Intern Med; 2022 Oct; 175(10):1392-1400. PubMed ID: 36191315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The present and future treatment of pediatric type 2 diabetes.
    Van Name MA; Guandalini C; Steffen A; Patel A; Tamborlane W
    Expert Rev Endocrinol Metab; 2018 Jul; 13(4):207-212. PubMed ID: 30063424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical trial to maintain glycemic control in youth with type 2 diabetes.
    ; Zeitler P; Hirst K; Pyle L; Linder B; Copeland K; Arslanian S; Cuttler L; Nathan DM; Tollefsen S; Wilfley D; Kaufman F
    N Engl J Med; 2012 Jun; 366(24):2247-56. PubMed ID: 22540912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of type 2 diabetes mellitus in youth : which therapies?
    Miller JL; Silverstein JH
    Treat Endocrinol; 2006; 5(4):201-10. PubMed ID: 16878999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight change in the management of youth-onset type 2 diabetes: the TODAY clinical trial experience.
    Marcus MD; Wilfley DE; El Ghormli L; Zeitler P; Linder B; Hirst K; Ievers-Landis CE; van Buren DJ; Walders-Abramson N;
    Pediatr Obes; 2017 Aug; 12(4):337-345. PubMed ID: 27161901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycemia and Gluconeogenesis With Metformin and Liraglutide: A Randomized Trial in Youth-onset Type 2 Diabetes.
    Dietsche KB; Magge SN; Dixon SA; Davis FS; Krenek A; Chowdhury A; Mabundo L; Stagliano M; Courville AB; Yang S; Turner S; Cai H; Kasturi K; Sherman AS; Ha J; Shouppe E; Walter M; Walter PJ; Chen KY; Brychta RJ; Peer C; Zeng Y; Figg W; Cogen F; Estrada DE; Chacko S; Chung ST
    J Clin Endocrinol Metab; 2024 Apr; 109(5):1361-1370. PubMed ID: 37967247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Youth-onset type 2 diabetes: translating epidemiology into clinical trials.
    Pyle L; Kelsey MM
    Diabetologia; 2021 Aug; 64(8):1709-1716. PubMed ID: 34075436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study.
    Diabetes Prevention Program Research Group
    Lancet Diabetes Endocrinol; 2015 Nov; 3(11):866-75. PubMed ID: 26377054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Add-on therapies to metformin for type 2 diabetes.
    Shomali M
    Expert Opin Pharmacother; 2011 Jan; 12(1):47-62. PubMed ID: 21142694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment patterns and associated factors in 14 668 people with type 2 diabetes initiating a second-line therapy: Results from the global DISCOVER study programme.
    Nicolucci A; Charbonnel B; Gomes MB; Khunti K; Kosiborod M; Shestakova MV; Shimomura I; Watada H; Chen H; Cid-Ruzafa J; Fenici P; Hammar N; Surmont F; Tang F; Pocock S
    Diabetes Obes Metab; 2019 Nov; 21(11):2474-2485. PubMed ID: 31297947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin & lifestyle intervention prevent Type 2 diabetes: lifestyle intervention has the greater effect.
    Doggrell SA
    Expert Opin Pharmacother; 2002 Jul; 3(7):1011-3. PubMed ID: 12084000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologic and weight-focused treatment strategies for managing type 2 diabetes mellitus: the metformin, glucagon-like peptide-1 receptor agonist, and insulin (MGI) approach.
    Nadeau DA
    Postgrad Med; 2013 May; 125(3):112-26. PubMed ID: 23748512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of Type 2 Diabetes: a Practical Approach].
    Donath M
    Praxis (Bern 1994); 2016 Jun; 105(12):699-702. PubMed ID: 27269776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology: Non-Insulin Agents.
    O'Brien H; Travis C
    Prim Care; 2022 Jun; 49(2):315-326. PubMed ID: 35595485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.